These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
939 related items for PubMed ID: 12733148
1. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G. Cancer; 2003 May 15; 97(10):2487-97. PubMed ID: 12733148 [Abstract] [Full Text] [Related]
2. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance. Ionescu DN, Treaba D, Gilks CB, Leung S, Renouf D, Laskin J, Wood-Baker R, Gown AM. Am J Surg Pathol; 2007 Jan 15; 31(1):26-32. PubMed ID: 17197916 [Abstract] [Full Text] [Related]
3. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Howe MC, Chapman A, Kerr K, Dougal M, Anderson H, Hasleton PS. Histopathology; 2005 Feb 15; 46(2):195-201. PubMed ID: 15693892 [Abstract] [Full Text] [Related]
4. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer. Petrović M, Baskić D, Banković D, Ilić N. Biomarkers; 2011 Jun 15; 16(4):311-20. PubMed ID: 21595568 [Abstract] [Full Text] [Related]
5. Chromogranin A gene expression in non-small cell lung carcinomas. Abbona G, Papotti M, Viberti L, Macrĭ L, Stella A, Bussolati G. J Pathol; 1998 Oct 15; 186(2):151-6. PubMed ID: 9924430 [Abstract] [Full Text] [Related]
6. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T. Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846 [Abstract] [Full Text] [Related]
7. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Cancer; 2006 Oct 01; 107(7):1467-74. PubMed ID: 16955509 [Abstract] [Full Text] [Related]
8. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance]. Ouyang N, Chen G, Ding J. Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb 01; 24(2):90-2. PubMed ID: 11802946 [Abstract] [Full Text] [Related]
9. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases. Castro CY, Stephenson M, Gondo MM, Medeiros LJ, Cagle PT. Mod Pathol; 2000 Jul 01; 13(7):808-13. PubMed ID: 10912942 [Abstract] [Full Text] [Related]
10. Neuroendocrine differentiation in non-small cell lung carcinomas. Baldi A, Groger AM, Esposito V, Di Marino MP, Ferrara N, Baldi F. In Vivo; 2000 Jul 01; 14(1):109-14. PubMed ID: 10757067 [Abstract] [Full Text] [Related]
11. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF. Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154 [Abstract] [Full Text] [Related]
12. Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung. González-Aragoneses F, Moreno-Mata N, Cebollero-Presmanes M, García-Yuste M, Cañizares-Carretero MA, Molins-López-Rodó L, Quevedo-Losada S, Torres-Lanzas J, Alvarez-Fernández E, Spanish Multicenter Study of Neuroendocrine Tumours of the Lung of the Spanish Society of Pneumonology, ThoracicSurgery (EMETNE-SEPAR). Cancer; 2007 Oct 15; 110(8):1776-81. PubMed ID: 17724707 [Abstract] [Full Text] [Related]
13. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S, O'Lear S. Cancer Res; 1994 Jun 01; 54(11):2908-13. PubMed ID: 8187076 [Abstract] [Full Text] [Related]
14. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT, Shang L, Cao J, Song X, Wang BS, Cai Y, Zhan QM, Wang MR. Lung Cancer; 2012 Jul 01; 77(1):176-82. PubMed ID: 22456526 [Abstract] [Full Text] [Related]
15. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. Iyoda A, Hiroshima K, Moriya Y, Sekine Y, Shibuya K, Iizasa T, Nakatani Y, Fujisawa T. J Thorac Cardiovasc Surg; 2006 Aug 01; 132(2):312-5. PubMed ID: 16872955 [Abstract] [Full Text] [Related]
16. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Jiang SX, Kameya T, Shinada J, Yoshimura H. Mod Pathol; 1999 Apr 01; 12(4):362-9. PubMed ID: 10229500 [Abstract] [Full Text] [Related]
17. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G. Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326 [Abstract] [Full Text] [Related]
18. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370 [Abstract] [Full Text] [Related]
19. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha). Dirnhofer S, Freund M, Rogatsch H, Krabichler S, Berger P. Hum Pathol; 2000 Aug 15; 31(8):966-72. PubMed ID: 10987258 [Abstract] [Full Text] [Related]
20. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung. Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT. Mod Pathol; 2000 Nov 15; 13(11):1167-72. PubMed ID: 11106072 [Abstract] [Full Text] [Related] Page: [Next] [New Search]